Review
Published on 21 Aug 2025
Epigenetic regulation of bladder cancer in the context of aging
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617452
- 534 views
Type at least 3 characters
620 articles
Original Research
Published on 21 Aug 2025
Analysis of six CYP450 genetic variants regarding the response to cannabidiol combined with anticonvulsant medication in mexican patients with drug-resistant epilepsy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626054
- 414 views
Original Research
Accepted on 20 Aug 2025
Higher Prevalence of NUDT15 rs116855232 Compared to TPMT rs1142345 in a Chinese Cohort and Its Implications for Thiopurine Therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660719
Original Research
Accepted on 19 Aug 2025
Pharmacogenomic Biomarkers of ACE Inhibitor–Induced Cough in a Multi-Ethnic UAE Cohort
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655617
- 192 views
Original Research
Accepted on 18 Aug 2025
Pharmacogenomics and Genetic Ancestry in Colombia: A Study on All Variant Drug Annotations of PharmGKB
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636451
- 121 views
Original Research
Published on 15 Aug 2025
Population-specific genetic differences of acute coronary syndrome in Han and Uyghur Chinese
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588658
- 993 views
Original Research
Accepted on 14 Aug 2025
A Multi-Centre Observational Cohort Study on Pharmacogenomic Predictors of Rosuvastatin Discontinuation in a Multiethnic Population
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1656520
- 217 views
Brief Research Report
Accepted on 12 Aug 2025
Comparative evaluation of Oxford Nanopore Technologies' adaptive sampling and the Twist long-read PGx panel for pharmacogenomic profiling
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1653999
- 213 views
Review
Published on 12 Aug 2025
Role of pharmacogenomics for prevention of hypersensitivity reactions induced by aromatic antiseizure medications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1640401
- 544 views
Correction
Published on 08 Aug 2025
Correction: Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1/CXCR4 axis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660169
- 295 views
Review
Published on 07 Aug 2025
Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1600787
- 1,395 views
Clinical Trial
Published on 07 Aug 2025
Clinicians’ experience on the effectiveness of pharmacotherapy in patients with first-episode depression: a randomized controlled trial based on pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626654
- 394 views
Review
Published on 07 Aug 2025
The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1634703
- 518 views
Original Research
Accepted on 05 Aug 2025
Prevalence of risk phenotypes associated with CYP2C9*2, *3 and VKORC1 c.-1639G>A genetic polymorphisms in the world populations: Implications in clinical practice
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1597379
- 130 views
Original Research
Accepted on 28 Jul 2025
The prevalence of Ggenetic variants of the Mas-related G-proteincoupled receptor X2 in patients experiencing does not explain perioperative hypersensitivity reactions to neuromuscular blocking agents
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655722
- 280 views
Original Research
Published on 21 Jul 2025
Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1614753
- 865 views